Renal and metabolic effects of insulin lispro in type 2 diabetic subjects with overt nephropathy

Diabetes Care

Volumn 26, Issue 2, 2003, Pages 502-509

  Ruggenenti, Piero ^a,b   Flores, Claudio ^a   Aros, Claudio ^a   Ene Iordache, Bogdan ^a   Trevisan, Roberto ^b   Ottomano, Cosimo ^b   Remuzzi, Giuseppe ^a,b  

^a MARIO NEGRI INST PHARMACOL RES   (Italy)

^b OSPEDALI RIUNITI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN LISPRO; SOMATOMEDIN C; ANTIDIABETIC AGENT; DRUG DERIVATIVE; INSULIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIABETIC NEPHROPATHY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; GLOMERULUS FILTRATION RATE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY PLASMA FLOW; KIDNEY VASCULAR RESISTANCE; MALE; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; URINARY EXCRETION; ALBUMINURIA; BLOOD; GLUCOSE CLAMP TECHNIQUE; KIDNEY; KIDNEY CIRCULATION; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; POSTPRANDIAL STATE; URINE; VASCULAR RESISTANCE;

ADULT; AGED; ALBUMINURIA; BLOOD GLUCOSE; CROSS-OVER STUDIES; DIABETIC NEPHROPATHIES; FEMALE; GLOMERULAR FILTRATION RATE; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; KIDNEY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POSTPRANDIAL PERIOD; RENAL CIRCULATION; VASCULAR RESISTANCE;

EID: 0038052137     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.26.2.502     Document Type: Article

References (40)

1. Deen WM, Maddox DA, Robertson CR, Brenner BM: Dynamics of glomerular ultrafiltration in the rat. VII. Response to reduced renal mass. Am J Physiol 227:556-562, 1974
2. Brenner BM, Meyer TW, Hostetter TH: Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med 307:652-659, 1982
3. Mogensen CE, Christensen CK: Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 311:89-93, 1984
4. Castellino P, Levin R, Shohat J, De Fronzo RA: Effect of specific amino acid groups on renal hemodynamics in humans. Am J Physiol 258:F992-F997, 1990
5. Parving HH, Christiansen JS, Noer I, Tronier B, Mogensen CE: The effect of glucagon infusion on kidney function in short term insulin dependent juvenile diabetes. Diabetologia 19:350-354, 1980
6. Christiansen JS, Gammelgaard J, Frandsen M, Orskov H, Parving HH: Kidney function and size in type I diabetic patients before and during growth hormone administration for one week. Diabetologia 22:333-337, 1982
7. Trevisan R, Nosadini R, Fioretto P: Keton bodies increase glomerular filtration rate in normal men and in patients with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 30:214, 1997
8. Hirschberg R, Kopple JD: Increase in renal plasma flow and glomerular filtration rate during growth hormone treatment may be mediated by insulin-like growth factor I. Am J Nephrol 8:249-253, 1988
9. Hammerman MR: The growth hormone-insulin-like growth factor axis in kidney re-visited. Nephrol Dial Transplant 14:1853-1860, 1999
10. Enberg G, Hall K: Immunoreactive IGF-II in serum of healthy subjects and patients with growth hormone disturbances and uremia. Acta Endocrinol 107:164-170, 1984
11. Miller SB, Rotwein P, Bortz JD, Bechtel PJ, Hansen VA, Rogers SA, Hammerman MR: Renal expression of IGF-I in hypersomatotropic states. Am J Physiol 259:F251-F257, 1990
12. Zapf J, Froesch ER: Pathophysiological and clinical aspects of insulin-like growth factors. Hormone Res 24:160-165, 1986
13. Verrotti A, Cieri F, Petitti MT, Morgese G, Chiarelli F: Growth hormone and IGF-I in diabetic children with and without microalbuminuria. Diabetes Nutr Metab 12:271-276, 1999
14. Hirschberg R, Kopple JD: Evidence that insulin-like growth factor I increases renal plasma flow and glomerular filtration rate in fasted rats. J Clin Invest 83:326-330, 1989
15. Hirschberg R, Blantz RC, Kopple JD, Tucker BJ: Effects of recombinant human insulin-like growth factor I on glomerular dynamics in the rat. J Clin Invest 87:1200-1206, 1991
16. Guler HP, Eckardt KU, Zapf J, Bauer C, Froesch ER: Insulin-like growth factor I increases glomerular filtration rate and renal plasma flow in man. Acta Endocrinol 121:101-106, 1989
17. Guler HP, Schmid C, Zapf J, Froesch ER: Effects of recombinant insulin-like growth factor I on insulin secretion and renal function in normal human subjects. Proc Natl Acad Sci U S A 86:2868-2872, 1989
18. Miller SB, Hansen VA, Hammerman MR: Effects of growth hormone and IGF-I on renal function in rats with normal and reduced renal mass. Am J Physiol 259:F747-F751, 1990
19. Aron DC, Rosenzweig JL, Abboud HE: Synthesis and binding of insulin-like growth factor 1 by human glomerular mesangial cells. J Clin Endocrinol Metab 68:585-591, 1989
20. Abboud HE: Growth factors and diabetic nephropathy: an overview. Kidney Int 52 (Suppl. 60):S3-S6, 1997
21. Haylor JL, McKillop IH, Oldroyd SD, El Nahas MA: IGF-I inhibitors reduce compensatory hyperfiltration in the isolated rat kidney following unilateral nephrectomy. Nephrol Dial Transplant 15:87-92, 2000
22. Haylor JL, Hickling H, El Eter E, Moir A, Oldroyd S, Hardisty C, El-Nahas AM: JB3, an IGF-I receptor antagonist, inhibits early renal growth in diabetic and uninephrectomized rats. J Am Soc Nephrol 11:2027-2035, 2000
23. Flyvbjerg A, Landau D, Domene H, Hernandez L, Gronbaek H, LeRoith D: The role of growth hormone, insulin-like growth factors (IGFs), and IGF-binding proteins in experimental diabetic kidney disease. Metabolism 44 (Suppl. 4):67-71, 1995
24. Flyvbjerg A: Role of growth hormone, insulin-like growth factors (IGFs) and IGF-binding proteins in the renal complications of diabetes. Kidney Int 52 (Suppl. 60):S12-S19, 1997
25. Miyatake N, Shikata K, Wada J, Sugimoto H, Takahashi S-I, Makino H: Differential distribution of insulin-like growth factor-1 and insulin-like growth factor binding proteins in experimental diabetic rat kidney. Nephron 81:317-323, 1999
26. Slieker LJ, Brooke GS, Di Marchi RD, Flora DB, Green LK, Hoffmann JA, Long HB, Fan L, Shields JE, Sundell KL, Surface PL, Chance RE: Modifications in the B10 and B26-30 regions of the B chain of human insulin alter affinity for the human IGF-I receptor more than for the insulin receptor. Diabetologia 40:S54-S61, 1997
27. Slieker LJ, Brooke GS, Chanee RE, Fan L, Hoffmann JA, Howey DC, Long HB, Mayer J, Shields JE, Sundell KL: Insulin and IGF-I analogs: novel approaches to improved insulin pharmacokinetics: current directions in insulin-like growth factor research. In Advances in Experimental Medicine and Biology. Vol. 343. LeRoith D, Raizada MK, Eds. New York, Plenum Press, 1994, p. 25-32
28. Holleman F, Hoekstra JBL: Insulin Lispro. N Engl J Med 337:176-183, 1997
29. Zatz R, Meyer TW, Rennke HG, Brenner BM: Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. Proc Natl Acad Sci U S A 82:5963-5967, 1985
30. Pampanelli S, Torlone E, Lalli C, Del Sindaco P, Ciofetta M, Lepore M, Bartocci L, Brunetti P, Bolli GB: Improved post-prandial metabolic control after subcutaneous injection of a short acting insulin analog in IDDM of short duration with residual pancreatic β-cell function. Diabetes Care 15:1452-1459, 1995
31. Bruttomesso D, Pianta A, Mari A, Valerio A, Marescotti MC, Avogaro A, Tiengo A, Del Prato S: Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients. Diabetes 48:99-105, 1999
32. Wilde MI, McTavish D: Insulin lispro: a review of its pharmacological properties and therapeutic use in the management of diabetes mellitus. Drugs 54:597-614, 1997
33. Woods LL: Mechanisms of renal hemodynamic regulation in response to protein feeding. Kidney Int 44:659-675, 1993
34. Remuzzi A, Viberti G, Ruggenenti P, Battaglia C, Pagni R, Remuzzi G: Glomerular response to hyperglycemia in human diabetic nephropathy. Am J Physiol 259: F545-F552, 1990
35. Heinemann L, Heise T, Walh LCh, Trautmann ME, Ampudia J, Starke AA, Berger M: Prandial glycaemia after a carbohydrate-rich meal in type I diabetic patients: using the rapid acting insulin analog [Lys (B28), pro (B29)] human insulin. Diabet Med 13:625-629, 1996
36. Nakagawa SH, Nakayama T, Sasaki Y, Yochinok K, Shinozaki S, Akoi S, Moshimo K: A simple method for the determination of serum free insulin levels in insulin-treated patients. Diabetes 22:590-600, 1973
37. Olsen DC: Determination of aminoacids in physiological fluids using liquid chromatography and fluorescence detection. Chromatogr News 7:22-26, 1979
38. Mosconi L, Ruggenenti P, Perna A, Mecca G, Remuzzi G: Nitrendipine and enalapril improve albuminuria and glomerular filtration rate in non-insulin dependent diabetes. Kidney Int 49 (Suppl. 55):S91-S93, 1996
39. Baron AD: Hemodynamic actions of insulin. Am J Physiol 267:E187-E202, 1994.
40. Luksch A, Polak K, Matulla B, Dallinger S, Kapiotis S, Wolzt M, Schmetterer L: Glucose and insulin exert additive ocular and vasodilator effect on healthy humans. Diabetologia 44:95-103, 2001